Cold sore treatment proven to be 100% effective:
This article was originally published in Clinica
Phase II trials of Viratrol, NexMed's hand-held, battery-operated device to treat recurrent herpes labialis (cold sores), have shown that the treatment is 100% effective. A low-level transdermic electric current lasting 20 seconds was applied hourly, eight times a day, to the cold sore. Patients participating in the trials were in the first 48 hours of an active herpes labialis outbreak. Within a day, 80% of patients reported the disappearance of pain and by the third day, none suffered pain and the lesions had disappeared. The company expects to complete Phase III trials by the third quarter of this year.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.